Skip to content
HowShorted

Citius Pharmaceuticals, Inc. short interest in 2026

In 2026, Citius Pharmaceuticals, Inc.'s disclosed short interest ran from 14.08% of shares outstanding on 15 Jan 2026 to 20.26% on 15 Sep 2026, a change of +6.18 percentage points. The year's high was 25.35% on 30 Apr 2026 and its low 13.10% on 30 Jan 2026, averaging 18.27% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.48 days on 15 Sep 2026. Full history: Citius Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Citius Pharmaceuticals, Inc. in 2026

2026 in figures

Start of year
14.08% (15 Jan 2026)
End of year
20.26% (15 Sep 2026)
Change
+6.18 pp
High
25.35% (30 Apr 2026)
Low
13.10% (30 Jan 2026)
Average
18.27%
Highest days to cover
27.48 (15 Sep 2026)
SEC filings marked
6

Every report in 2026

Citius Pharmaceuticals, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202614.08%9.96
30 Jan 202613.10%9.91
13 Feb 202615.07%4.3910-Q filed, results (8-K)
27 Feb 202616.10%11.60
13 Mar 202619.48%3.61
31 Mar 202618.81%6.86
15 Apr 202619.29%13.69
30 Apr 202625.35%4.28
15 May 202618.81%6.8210-Q filed, results (8-K)
29 May 202618.02%5.52
15 Jun 202617.79%14.73
30 Jun 202617.35%23.44
15 Jul 202618.15%26.04
31 Jul 202618.79%8.25
14 Aug 202619.55%5.3210-Q filed, results (8-K)
31 Aug 202620.51%6.06
15 Sep 202620.26%27.48

See also: Citius Pharmaceuticals, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.